RIL
PSTX

Rothschild Investment LLC’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Rothschild Investment LLC’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,060
Closed -$116K – 3121
2024
Q4 		$116K Buy
12,060
+60
+0.5% +$313 0.01% 605
2024
Q3 		$34.3K Hold
12,000
– – ﹤0.01% 869
2024
Q2 		$35K Hold
12,000
– – ﹤0.01% 837
2024
Q1 		$38.3K Hold
12,000
– – ﹤0.01% 789
2023
Q4 		$40.3K Hold
12,000
– – ﹤0.01% 699
2023
Q3 		$29K Hold
12,000
– – ﹤0.01% 475
2023
Q2 		$21K Hold
12,000
– – ﹤0.01% 487
2023
Q1 		$37K Hold
12,000
– – ﹤0.01% 481
2022
Q4 		$64K Hold
12,000
– – 0.01% 469
2022
Q3 		$42K Hold
12,000
– – ﹤0.01% 468
2022
Q2 		$31K Hold
12,000
– – ﹤0.01% 468
2022
Q1 		$54K Hold
12,000
– – ﹤0.01% 478
2021
Q4 		$82K Hold
12,000
– – 0.01% 489
2021
Q3 		$87K Hold
12,000
– – 0.01% 470
2021
Q2 		$120K Hold
12,000
– – 0.01% 471
2021
Q1 		$115K Hold
12,000
– – 0.01% 451
2020
Q4 		$132K Sell
12,000
-6,000
-33% -$63.3K 0.01% 431
2020
Q3 		$160K Buy
+18,000
New +$205K 0.02% 400

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rothschild Investment LLC's PSTX Position: Q1 2025 in Review

Rothschild Investment LLC sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 12,060 shares — an estimated $116K sold.

Rothschild Investment LLC first reported a position in PSTX in Q3 2020 and held it in 18 quarters. The position peaked at $160K in Q3 2020. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Rothschild Investment LLC reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Rothschild Investment LLC sold 12,060 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $116K.
  • Rothschild Investment LLC first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Rothschild Investment LLC's Poseida Therapeutics, Inc. Common Stock position peaked at $160K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Rothschild Investment LLC's 13F filing for Q1 2025, filed 8 Apr 2025.